The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer - Concepedia

Concepedia

Publication | Open Access

The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer

DOI Full Paper Access

44

Citations

14

References

2020

Year

Ulrike Nitz, Oleg Gluz, Hans Kreipe, Matthias Christgen, Sherko Küemmel, Frederick L. Baehner, Steven Shak, Bahriye Aktas, Michael Braun, Kerstin Lüdtke-Heckenkamp,

Therapeutic Advances in Medical Oncology

Abstract

NCT01779206.

References

	Year	Citations

Page 1